Underlying EBITDA fell to €379 million amid margin pressure from higher input costs and lower selling prices, while revenue rose slightly to €3,975 million. Special items of €320 million, mainly impairments and restructuring, weighed on results, and capital expenditure guidance was reduced to €500 million.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.